Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
65
Views
9
CrossRef citations to date
0
Altmetric
Case Report

Treatment of adult brainstem glioma with combined antiangiogenic therapy: a case report and literature review

Dongdong Yu1 Department of Radiation Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, P.R. China
,
Guang Han2 Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, Hubei Province, P.R. China, [email protected]Correspondence[email protected]
,
Huali Liu3 Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, P.R. China
,
Likun Gao4 Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, P.R. China
&
Vivek Verma5 Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, USA
Pages 1333-1339 | Published online: 18 Feb 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yong Wang, Xiangji Meng, Shizhen Zhou, Yufang Zhu, Jun Xu & Rongjie Tao. (2019) Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study. OncoTargets and Therapy 12, pages 10579-10585.
Read now
Sheng-Li Sun, Yu-Gao Shu & Mei-Yi Tao. (2019) miR-503 Inhibits Proliferation, Migration, And Angiogenesis Of Glioma By Acting On VEGFA Through Targeting LRIG2. Cancer Management and Research 11, pages 10599-10608.
Read now

Articles from other publishers (7)

Hao Lin, Xinli Zhou, Xiaofang Sheng & Xiaohua Liang. (2023) Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma. Drugs in R&D 23:3, pages 239-244.
Crossref
Liang Xia, Mingjie Gong, Yangfan Zou, Zeng Wang, Bin Wu, Shuyuan Zhang, Liwen Li, Kai Jin & Caixing Sun. (2022) Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway. Oxidative Medicine and Cellular Longevity 2022, pages 1-15.
Crossref
Annette Leibetseder, Johannes Leitner, Maximilian J. Mair, Stephan Meckel, Johannes A. Hainfellner, Martin Aichholzer, Georg Widhalm, Karin Dieckmann, Serge Weis, Julia Furtner, Tim von Oertzen, Matthias Preusser, Josef Pichler & Anna Sophie Berghoff. (2021) Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature. Journal of Neurology 269:3, pages 1574-1590.
Crossref
Hui Yao, Jiangang Liu, Chi Zhang, Yunxiang Shao, Xuetao Li, Zhengquan Yu & Yulun Huang. (2021) Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis. Cell Death & Disease 12:10.
Crossref
Hui Yao, Jiangang Liu, Chi Zhang, Yunxiang Shao, Xuetao Li, Ming Feng, Ximing Wang, Wenjuan Gan, Youxin Zhou & Yulun Huang. (2021) Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas. Journal of Clinical Neuroscience 90, pages 82-88.
Crossref
Panagiotis Kerezoudis, Anshit Goyal, Victor M. Lu, Mohammed Ali Alvi, Mohamad Bydon, Sani H. Kizilbash & Terry C. Burns. (2019) The role of radiation and chemotherapy in adult patients with high-grade brainstem gliomas: results from the National Cancer Database. Journal of Neuro-Oncology 146:2, pages 303-310.
Crossref
. (2019) Rivoceranib/temozolomide. Reactions Weekly 1753:1, pages 303-303.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.